Group 1 - The core viewpoint of the news is that Kangtong Medical has shown fluctuations in its stock performance and financial metrics, indicating potential investment opportunities and risks [1][2]. - On January 30, Kangtong Medical's stock rose by 0.80%, with a trading volume of 46.87 million yuan. The net financing buy was -237,400 yuan, with a total financing and margin balance of 142 million yuan, which is 8.48% of its market capitalization [1]. - The company has a high financing balance, exceeding the 90th percentile of the past year, indicating strong investor interest [1]. Group 2 - As of January 20, the number of shareholders for Kangtong Medical decreased by 17.81% to 9,594, while the average number of circulating shares per person increased by 21.67% to 6,834 shares [2]. - For the period from January to September 2025, Kangtong Medical reported a revenue of 344 million yuan, a year-on-year decrease of 30.06%, and a net profit attributable to shareholders of -10.21 million yuan, a decline of 150.92% [2]. - Since its A-share listing, Kangtong Medical has distributed a total of 48.99 million yuan in dividends [3].
港通医疗1月30日获融资买入279.63万元，融资余额1.42亿元